Market Overview:
The global meclofenoxate hydrochloride market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing incidence of traumatic coma, alcoholism, and others. In addition, rising awareness about the benefits of meclofenoxate hydrochloride is also contributing to the growth of this market. However, stringent regulatory norms are restraining the growth of this market. Based on type, the global meclofenoxate hydrochloride market is segmented into capsule and injection. The capsule segment accounted for a larger share in 2017 and is expected to maintain its dominance during the forecast period owing to its ease-of-use and lesser side effects as compared to injection form. Based on application, the global meclofenoxate hydrochloride market is segmented into traumatic coma, alcoholism rehabilitation center (ARC), and others (elderly care home). Alcoholism rehabilitation center (ARC) held a dominant share in 2017 due to increasing number of alcoholics across different geographies worldwide coupled with rising demand for effective treatment options for alcohol addiction disorders such as rehab centers/centers offering specialized treatments such as detoxification & rehabilitation therapies etc.). However; traumatic coma segment would grow at highest CAGR over next 10 years due high potential associated with it across globe followed by elderly care home which has already started witnessing traction in developed countries only .
Product Definition:
Meclofenoxate Hydrochloride is a drug that is used to improve memory and thinking skills. It works by increasing the amount of acetylcholine, a chemical in the brain that helps with these tasks.
Capsule:
Capsule is a small package of drugs or pharmaceutical products containing drug ingredients. It helps to protect the active ingredient from light, moisture and other physical agents which can help the medicine to remain effective for a longer time. The size and shape of capsule are decided based on the type of drug it is supposed to deliver; capsules for oral administration are available in two forms: gelatin (bovine) capsules and hard gelatin (porcine) capsules.
Injection:
Injection is a drug form of meclofenoxate, which is used as an anti-inflammatory drug. It reduces the inflammation caused by arthritis. It works by decreasing the production of cytokines and chemokines that are responsible for causing inflammation.
Application Insights:
Alcoholism segment led the global market in 2017 and is projected to continue its dominance over the forecast period. The drug has a significant impact on alcoholics as it normalizes their blood pressure, reduces anxiety and stabilizes mood swings caused by acute alcoholism. It also helps in treating withdrawal symptoms when alcohol is completely stopped. In severe cases of alcoholism, meclofenoxate can be used in conjunction with other medications for better results.
Traumatic Coma was the second largest application of meclofenoxate hydrochloride after alcoholism and accounted for 23% of total revenue share in 2017 due to rising incidence of traumatic brain injuries across the globe. According to data published by CDC, around 2-3 million people suffer from traumatic brain injury every year in U.S.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a growth rate of 5.6% over the forecast period, owing to increasing cases of brain injuries and trauma cases leading to Coma patients. According to the National Center for Health Statistics (NCHS), in 2015 about 3,853,thumbnails were reported in U.S.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace. This will lead to an increase in the demand for meclofenoxate hydrochloride, as it is beneficial for elderly people.
- Rising prevalence of Alzheimer’s disease: The prevalence of Alzheimer’s disease is rising at a rapid pace, due to the aging population. This will lead to an increase in the demand for meclofenoxate hydrochloride, as it can help improve cognitive function in patients with Alzheimer’s disease.
- Growing awareness about benefits of meclofenoxate hydrochloride: There is growing awareness about the benefits of meclofenoxate hydrochloride among healthcare professionals and consumers alike. This will lead to an increase in its demand in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Meclofenoxate Hydrochloride Market Research Report
By Type
Capsule, Injection
By Application
Traumatic Coma, Alcoholism, Others
By Companies
AdvaCare Pharma, Shanxi Pude Pharmaceutical Co., Ltd., Shandong Luoxin Pharmaceutical Group Co., Ltd., Ruiyang Pharmaceutical Co., Ltd., Chongqing Yaoyou Pharmaceutical Co., Ltd., Nanjing Haichen Pharmaceutical Co., Ltd., Bidiphar, Hainan Lingkang Pharmaceutical Co., Ltd., Nanjing Shenghe Pharmaceutical Co., Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Meclofenoxate Hydrochloride Market Report Segments:
The global Meclofenoxate Hydrochloride market is segmented on the basis of:
Types
Capsule, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Traumatic Coma, Alcoholism, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AdvaCare Pharma
- Shanxi Pude Pharmaceutical Co., Ltd.
- Shandong Luoxin Pharmaceutical Group Co., Ltd.
- Ruiyang Pharmaceutical Co., Ltd.
- Chongqing Yaoyou Pharmaceutical Co., Ltd.
- Nanjing Haichen Pharmaceutical Co., Ltd.
- Bidiphar
- Hainan Lingkang Pharmaceutical Co., Ltd.
- Nanjing Shenghe Pharmaceutical Co., Ltd.
Highlights of The Meclofenoxate Hydrochloride Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Capsule
- Injection
- By Application:
- Traumatic Coma
- Alcoholism
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Meclofenoxate Hydrochloride Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Meclofenoxate hydrochloride is a medication used to treat pain and inflammation. It is also used to reduce the risk of injury in athletes. Meclofenoxate hydrochloride works by blocking the action of chemicals that cause inflammation.
Some of the major players in the meclofenoxate hydrochloride market are AdvaCare Pharma, Shanxi Pude Pharmaceutical Co., Ltd., Shandong Luoxin Pharmaceutical Group Co., Ltd., Ruiyang Pharmaceutical Co., Ltd., Chongqing Yaoyou Pharmaceutical Co., Ltd., Nanjing Haichen Pharmaceutical Co., Ltd., Bidiphar, Hainan Lingkang Pharmaceutical Co., Ltd., Nanjing Shenghe Pharmaceutical Co., Ltd..
The meclofenoxate hydrochloride market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Meclofenoxate Hydrochloride Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Meclofenoxate Hydrochloride Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Meclofenoxate Hydrochloride Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Meclofenoxate Hydrochloride Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Meclofenoxate Hydrochloride Market Size & Forecast, 2020-2028
4.5.1 Meclofenoxate Hydrochloride Market Size and Y-o-Y Growth
4.5.2 Meclofenoxate Hydrochloride Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Capsule
5.2.2 Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Traumatic Coma
6.2.2 Alcoholism
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Meclofenoxate Hydrochloride Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Meclofenoxate Hydrochloride Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Capsule
9.6.2 Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Traumatic Coma
9.10.2 Alcoholism
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Capsule
10.6.2 Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Traumatic Coma
10.10.2 Alcoholism
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Capsule
11.6.2 Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Traumatic Coma
11.10.2 Alcoholism
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Capsule
12.6.2 Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Traumatic Coma
12.10.2 Alcoholism
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Capsule
13.6.2 Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Traumatic Coma
13.10.2 Alcoholism
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Meclofenoxate Hydrochloride Market: Competitive Dashboard
14.2 Global Meclofenoxate Hydrochloride Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AdvaCare Pharma
14.3.2 Shanxi Pude Pharmaceutical Co., Ltd.
14.3.3 Shandong Luoxin Pharmaceutical Group Co., Ltd.
14.3.4 Ruiyang Pharmaceutical Co., Ltd.
14.3.5 Chongqing Yaoyou Pharmaceutical Co., Ltd.
14.3.6 Nanjing Haichen Pharmaceutical Co., Ltd.
14.3.7 Bidiphar
14.3.8 Hainan Lingkang Pharmaceutical Co., Ltd.
14.3.9 Nanjing Shenghe Pharmaceutical Co., Ltd.
